| scholarly article | Q13442814 |
| P2093 | author name string | David B Teplow | |
| Maya Koronyo-Hamaoui | |||
| Yosef Koronyo | |||
| Keith L Black | |||
| Ueli Rutishauser | |||
| Songlin Li | |||
| Altan Rentsendorj | |||
| Eric Y Hayden | |||
| Julia Sheyn | |||
| Tania Torbati | |||
| Dieu-Trang Fuchs | |||
| Veronica J Garcia | |||
| David A Daley | |||
| P2860 | cites work | A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease | Q22241518 |
| TREM2 Variants in Alzheimer's Disease | Q22250873 | ||
| Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis | Q24323318 | ||
| Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease | Q24534813 | ||
| Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory | Q24645499 | ||
| Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior | Q24645994 | ||
| Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake | Q24656613 | ||
| Innate immune memory in the brain shapes neurological disease hallmarks | Q59071784 | ||
| The identity and function of microglia in neurodegeneration | Q61772849 | ||
| Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein | Q74736370 | ||
| Sex-dependent co-occurrence of hypoxia and β-amyloid plaques in hippocampus and entorhinal cortex is reversed by long-term treatment with ubiquinol and ascorbic acid in the 3 × Tg-AD mouse model of Alzheimer's disease | Q89314050 | ||
| Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease | Q90139981 | ||
| Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE | Q90929156 | ||
| Microglia in Alzheimer's disease: A target for immunotherapy | Q91375402 | ||
| Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain | Q91590650 | ||
| Soluble Aβ Oligomers Impair Dipolar Heterodendritic Plasticity by Activation of mGluR in the Hippocampal CA1 Region | Q91625829 | ||
| High molecular weight amyloid β1-42 oligomers induce neurotoxicity via plasma membrane damage | Q91987163 | ||
| What Is the "Relevant" Amyloid β42 Concentration? | Q92141945 | ||
| Synaptic Elimination in Neurological Disorders | Q92509987 | ||
| Phosphoproteomics of Alzheimer disease brain: Insights into altered brain protein regulation of critical neuronal functions and their contributions to subsequent cognitive loss | Q92545876 | ||
| Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model | Q92757004 | ||
| Deficits in Enrichment-Dependent Neurogenesis and Enhanced Anxiety Behaviors Mediated by Expression of Alzheimer's Disease-Linked Ps1 Variants Are Rescued by Microglial Depletion | Q92884177 | ||
| Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies | Q58780923 | ||
| Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1 | Q24676445 | ||
| A simple method for displaying the hydropathic character of a protein | Q26778481 | ||
| Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease. | Q27303708 | ||
| The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
| Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo | Q28131779 | ||
| Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease | Q28275105 | ||
| NeuriteTracer: a novel ImageJ plugin for automated quantification of neurite outgrowth | Q28364771 | ||
| Folding events in the 21-30 region of amyloid beta-protein (Abeta) studied in silico | Q28383620 | ||
| Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways | Q28579410 | ||
| Tau reduction prevents Abeta-induced defects in axonal transport. | Q28585545 | ||
| Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway | Q28854318 | ||
| A beta oligomers - a decade of discovery | Q29615152 | ||
| Preparation of pure populations of covalently stabilized amyloid β-protein oligomers of specific sizes | Q30394852 | ||
| Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline | Q30572684 | ||
| Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease | Q33709263 | ||
| Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS. | Q33988381 | ||
| Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins | Q34083143 | ||
| Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brain | Q34274025 | ||
| Coding variants in TREM2 increase risk for Alzheimer's disease | Q34307280 | ||
| Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model | Q34349078 | ||
| Contribution of Alzheimer disease to mortality in the United States | Q34408452 | ||
| Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways | Q34468169 | ||
| Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease | Q34544243 | ||
| Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins | Q34574518 | ||
| Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury | Q34671588 | ||
| Photo-induced cross-linking of unmodified proteins (PICUP) applied to amyloidogenic peptides. | Q34948679 | ||
| Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease | Q35643397 | ||
| Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology | Q36018333 | ||
| Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer's disease | Q36180652 | ||
| Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer's disease-like mice | Q36180666 | ||
| Cancer cell-selective killing polymer/copper combination. | Q36372931 | ||
| Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease | Q36402221 | ||
| A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer's models. | Q47874558 | ||
| Seed-induced Aβ deposition is modulated by microglia under environmental enrichment in a mouse model of Alzheimer's disease. | Q48139300 | ||
| Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease | Q48247414 | ||
| Microglial transplantation increases amyloid-beta clearance in Alzheimer model rats | Q48302618 | ||
| TREM2 analysis and increased risk of Alzheimer's disease | Q48511443 | ||
| Amyloid-β alters ongoing neuronal activity and excitability in the frontal cortex | Q48797116 | ||
| Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer's disease. | Q48863731 | ||
| Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease | Q48920532 | ||
| Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor | Q48933977 | ||
| Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. | Q49149683 | ||
| Gamma oscillations in the entorhinal-hippocampal circuit underlying memory and dementia. | Q50039492 | ||
| Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice. | Q51811574 | ||
| Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model. | Q53287908 | ||
| A histone acetylome-wide association study of Alzheimer's disease identifies disease-associated H3K27ac differences in the entorhinal cortex | Q57804842 | ||
| Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease | Q58573301 | ||
| Melanopsin retinal ganglion cell loss in Alzheimer disease | Q36533171 | ||
| GDF10 is a signal for axonal sprouting and functional recovery after stroke. | Q36682829 | ||
| Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages | Q36713193 | ||
| Microglial immunophenotype in dementia with Alzheimer's pathology. | Q36960714 | ||
| Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice | Q37003128 | ||
| Developing preventive therapies for chronic diseases: lessons learned from Alzheimer's disease | Q37073944 | ||
| Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization | Q37199687 | ||
| Targeting beta-amyloid pathology in Alzheimer's disease with Abeta immunotherapy | Q37215851 | ||
| Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. | Q37270464 | ||
| Complement and microglia mediate early synapse loss in Alzheimer mouse models. | Q37391481 | ||
| The role of osteopontin in inflammatory processes | Q37424204 | ||
| Alzheimer's disease: synaptic dysfunction and Abeta | Q37636545 | ||
| Entorhinal Cortex dysfunction can be rescued by inhibition of microglial RAGE in an Alzheimer's disease mouse model | Q37638090 | ||
| Osteopontin in macrophage function | Q37872380 | ||
| Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease | Q37915580 | ||
| Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment | Q37985523 | ||
| Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where | Q38021993 | ||
| Microglia in Alzheimer's disease: the good, the bad and the ugly | Q38633294 | ||
| A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease | Q38672340 | ||
| Immunization with a Myelin-Derived Antigen Activates the Brain's Choroid Plexus for Recruitment of Immunoregulatory Cells to the CNS and Attenuates Disease Progression in a Mouse Model of ALS. | Q38883240 | ||
| Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models | Q38891157 | ||
| Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes. | Q39135845 | ||
| Microglia Function in the Central Nervous System During Health and Neurodegeneration | Q39146780 | ||
| The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells | Q39926929 | ||
| Effect of chloroquine and leupeptin on intracellular accumulation of amyloid-beta (A beta) 1-42 peptide in a murine N9 microglial cell line | Q40997357 | ||
| Early and selective impairments in axonal transport kinetics of synaptic cargoes induced by soluble amyloid β-protein oligomers | Q41340280 | ||
| Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease | Q41845723 | ||
| Intracellular amyloid β oligomers impair organelle transport and induce dendritic spine loss in primary neurons. | Q42004000 | ||
| Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice | Q42458205 | ||
| Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid | Q42755604 | ||
| Quantifying synapses: an immunocytochemistry-based assay to quantify synapse number | Q42872734 | ||
| Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease | Q45877904 | ||
| TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. | Q45972218 | ||
| Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. | Q45987825 | ||
| Design, Characterization, and Use of a Novel Amyloid β-Protein Control for Assembly, Neurotoxicity, and Gene Expression Studies | Q46092870 | ||
| Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex. | Q46753990 | ||
| Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease | Q46942969 | ||
| Rapid photochemical cross-linking--a new tool for studies of metastable, amyloidogenic protein assemblies | Q47347367 | ||
| Preparation of aggregate-free, low molecular weight amyloid-beta for assembly and toxicity assays. | Q47376910 | ||
| The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases | Q47568641 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 49 | |
| P577 | publication date | 2020-01-31 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Activated Bone Marrow-Derived Macrophages Eradicate Alzheimer's-Related Aβ42 Oligomers and Protect Synapses | |
| P478 | volume | 11 |
Search more.